UY31918A - Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento - Google Patents
Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamentoInfo
- Publication number
- UY31918A UY31918A UY0001031918A UY31918A UY31918A UY 31918 A UY31918 A UY 31918A UY 0001031918 A UY0001031918 A UY 0001031918A UY 31918 A UY31918 A UY 31918A UY 31918 A UY31918 A UY 31918A
- Authority
- UY
- Uruguay
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- medicinal product
- fgfr inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se proporcionan nuevos compuestos de fórmula (Ia) o (Ib): o sales farmacéuticamente aceptables de estos, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7388308P | 2008-06-19 | 2008-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31918A true UY31918A (es) | 2010-01-29 |
Family
ID=40935715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001031918A UY31918A (es) | 2008-06-19 | 2009-06-18 | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090318468A1 (es) |
EP (1) | EP2328872A1 (es) |
JP (1) | JP2011524888A (es) |
KR (1) | KR20110020904A (es) |
CN (1) | CN102123989A (es) |
AR (1) | AR072261A1 (es) |
AU (1) | AU2009261683A1 (es) |
BR (1) | BRPI0914233A2 (es) |
CA (1) | CA2728063A1 (es) |
CL (1) | CL2010001470A1 (es) |
CO (1) | CO6351726A2 (es) |
CR (1) | CR11857A (es) |
DO (1) | DOP2010000387A (es) |
EA (1) | EA201100030A1 (es) |
EC (1) | ECSP10010693A (es) |
IL (1) | IL210082A0 (es) |
MX (1) | MX2010014234A (es) |
PE (1) | PE20110062A1 (es) |
SV (1) | SV2010003767A (es) |
TW (1) | TW201002693A (es) |
UY (1) | UY31918A (es) |
WO (1) | WO2009153592A1 (es) |
ZA (1) | ZA201100471B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
JP2013514986A (ja) * | 2009-12-18 | 2013-05-02 | ノバルティス アーゲー | 血液癌の処置方法 |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
MX349120B (es) | 2012-02-28 | 2017-07-12 | Astellas Pharma Inc | Compuesto heterociclico aromatico que contiene nitrogeno. |
DK3176170T3 (en) | 2012-06-13 | 2019-01-28 | Incyte Holdings Corp | SUBSTITUTED TRICYCLIC RELATIONS AS FGFR INHIBITORS |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
PL403149A1 (pl) * | 2013-03-14 | 2014-09-15 | Celon Pharma Spółka Akcyjna | Nowe związki pochodne pirazolilobenzo[d]imidazolu |
WO2014139145A1 (en) * | 2013-03-15 | 2014-09-18 | Hutchison Medipharma Limited | Novel pyrimidine and pyridine compounds and usage thereof |
ES2893725T3 (es) | 2013-04-19 | 2022-02-09 | Incyte Holdings Corp | Heterocíclicos bicíclicos como inhibidores del FGFR |
AU2014291161B2 (en) | 2013-07-18 | 2018-04-26 | Taiho Pharmaceutical Co., Ltd. | Antitumor drug for intermittent administration of FGFR inhibitor |
JP6084292B2 (ja) | 2013-07-18 | 2017-02-22 | 大鵬薬品工業株式会社 | Fgfr阻害剤耐性癌の治療薬 |
AU2015304465B2 (en) | 2014-08-18 | 2019-05-09 | Eisai R&D Management Co., Ltd. | Salt of monocyclic pyridine derivative and crystal thereof |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
HUE051074T2 (hu) | 2015-03-31 | 2021-03-01 | Taiho Pharmaceutical Co Ltd | 3,5-diszubsztituált benzol alkinil vegyület kristálya |
US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
MA43807A (fr) * | 2016-03-04 | 2018-11-28 | Taiho Pharmaceutical Co Ltd | Préparation et composition de traitement de tumeurs malignes |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
EP3670513B1 (en) | 2017-08-15 | 2023-09-20 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Fgfr inhibitor and medical application thereof |
MA52093A (fr) | 2018-03-19 | 2021-01-27 | Taiho Pharmaceutical Co Ltd | Composition pharmaceutique comprenant du sulfate d'alkyle de sodium |
BR112020017922A2 (pt) | 2018-03-28 | 2020-12-22 | Eisai R&D Management Co., Ltd. | Agente terapêutico para carcinoma hepatocelular |
CN110317173B (zh) * | 2018-03-30 | 2022-10-11 | 上海奕拓医药科技有限责任公司 | 用作fgfr不可逆抑制剂的酰胺基吡唑类化合物 |
BR112020022392A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | formas sólidas de um inibidor de fgfr e processos para preparação das mesmas |
MA52493A (fr) | 2018-05-04 | 2021-03-10 | Incyte Corp | Sels d'un inhibiteur de fgfr |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
WO2020188015A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
CR20220169A (es) | 2019-10-14 | 2022-10-27 | Incyte Corp | Heterociclos bicíclicos como inhibidores de fgfr |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021113462A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
WO2022261160A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57150846A (en) * | 1981-03-13 | 1982-09-17 | Konishiroku Photo Ind Co Ltd | Photographic element |
JPH0511414A (ja) * | 1991-07-02 | 1993-01-22 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
AU664392B2 (en) * | 1991-10-18 | 1995-11-16 | Monsanto Technology Llc | Fungicides for the control of take-all disease of plants |
HRP921338B1 (en) * | 1992-10-02 | 2002-04-30 | Monsanto Co | Fungicides for the control of take-all disease of plants |
US6271237B1 (en) * | 1997-12-22 | 2001-08-07 | Dupont Pharmaceuticals Company | Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
GB9823103D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
CA2362381C (en) * | 1999-02-10 | 2009-12-22 | Welfide Corporation | Amide compounds and medicinal use thereof |
SK1812002A3 (en) * | 1999-08-12 | 2003-02-04 | Pharmacia Italia Spa | 3(5)-Amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
US6552008B1 (en) * | 1999-09-24 | 2003-04-22 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
EP1319657A4 (en) * | 2000-09-22 | 2005-03-02 | Nihon Nohyaku Co Ltd | N- (4-PYRAZOLYL AMIDE) DERIVATIVES, CHEMICALS FOR AGRICULTURAL AND HORTICULTURAL USE AND APPLICATIONS THEREOF |
ATE548031T1 (de) * | 2000-12-18 | 2012-03-15 | Inst Med Molecular Design Inc | Inhibitoren gegen die produktion und freisetzung entzündungfördernder zytokine |
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US20060019958A1 (en) * | 2002-06-05 | 2006-01-26 | Susumu Muto | Immunity-related protein kinase inhibitors |
EP1510207A4 (en) * | 2002-06-05 | 2008-12-31 | Inst Med Molecular Design Inc | THERAPEUTIC MEDICAMENT AGAINST DIABETES |
US20060122243A1 (en) * | 2002-06-06 | 2006-06-08 | Susumu Muto | Antiallergic |
US20060004010A1 (en) * | 2002-07-10 | 2006-01-05 | Hiromu Habashita | Ccr4 antagonist and medical use thereof |
EP1542999A1 (en) * | 2002-08-01 | 2005-06-22 | Pharmacia & Upjohn Company LLC | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
US20040220170A1 (en) * | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
US7115359B2 (en) * | 2003-07-25 | 2006-10-03 | Konica Minolta Medical & Graphic, Inc. | Photothermographic material |
US7432271B2 (en) * | 2003-09-02 | 2008-10-07 | Bristol-Myers Squibb Company | Pyrazolyl inhibitors of 15-lipoxygenase |
US7767670B2 (en) * | 2003-11-13 | 2010-08-03 | Ambit Biosciences Corporation | Substituted 3-carboxamido isoxazoles as kinase modulators |
US7652146B2 (en) * | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
US7253204B2 (en) * | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
JP2007535551A (ja) * | 2004-04-28 | 2007-12-06 | バーテックス ファーマシューティカルズ インコーポレイテッド | Rockおよび他のプロテインキナーゼの阻害剤として有用な組成物 |
US7737149B2 (en) * | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
-
2009
- 2009-06-17 CN CN2009801328063A patent/CN102123989A/zh active Pending
- 2009-06-17 AU AU2009261683A patent/AU2009261683A1/en not_active Abandoned
- 2009-06-17 MX MX2010014234A patent/MX2010014234A/es not_active Application Discontinuation
- 2009-06-17 EP EP09766153A patent/EP2328872A1/en not_active Withdrawn
- 2009-06-17 EA EA201100030A patent/EA201100030A1/ru unknown
- 2009-06-17 JP JP2011514127A patent/JP2011524888A/ja active Pending
- 2009-06-17 WO PCT/GB2009/050684 patent/WO2009153592A1/en active Application Filing
- 2009-06-17 CA CA2728063A patent/CA2728063A1/en not_active Abandoned
- 2009-06-17 PE PE2010001161A patent/PE20110062A1/es not_active Application Discontinuation
- 2009-06-17 KR KR1020117000437A patent/KR20110020904A/ko not_active Application Discontinuation
- 2009-06-17 BR BRPI0914233A patent/BRPI0914233A2/pt not_active Application Discontinuation
- 2009-06-18 UY UY0001031918A patent/UY31918A/es not_active Application Discontinuation
- 2009-06-18 TW TW098120493A patent/TW201002693A/zh unknown
- 2009-06-19 AR ARP090102262A patent/AR072261A1/es unknown
- 2009-06-19 US US12/487,838 patent/US20090318468A1/en not_active Abandoned
-
2010
- 2010-12-16 IL IL210082A patent/IL210082A0/en unknown
- 2010-12-17 DO DO2010000387A patent/DOP2010000387A/es unknown
- 2010-12-17 CL CL2010001470A patent/CL2010001470A1/es unknown
- 2010-12-17 EC EC2010010693A patent/ECSP10010693A/es unknown
- 2010-12-17 CR CR11857A patent/CR11857A/es not_active Application Discontinuation
- 2010-12-17 SV SV2010003767A patent/SV2010003767A/es not_active Application Discontinuation
-
2011
- 2011-01-18 ZA ZA2011/00471A patent/ZA201100471B/en unknown
- 2011-01-19 CO CO11005446A patent/CO6351726A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2010001470A1 (es) | 2011-05-06 |
SV2010003767A (es) | 2011-05-20 |
AU2009261683A1 (en) | 2009-12-23 |
US20090318468A1 (en) | 2009-12-24 |
CA2728063A1 (en) | 2009-12-23 |
CR11857A (es) | 2011-02-25 |
EA201100030A1 (ru) | 2011-08-30 |
IL210082A0 (en) | 2011-02-28 |
ECSP10010693A (es) | 2011-01-31 |
PE20110062A1 (es) | 2011-03-09 |
JP2011524888A (ja) | 2011-09-08 |
CN102123989A (zh) | 2011-07-13 |
MX2010014234A (es) | 2011-03-25 |
AR072261A1 (es) | 2010-08-18 |
DOP2010000387A (es) | 2012-09-30 |
TW201002693A (en) | 2010-01-16 |
EP2328872A1 (en) | 2011-06-08 |
KR20110020904A (ko) | 2011-03-03 |
ZA201100471B (en) | 2012-06-27 |
WO2009153592A1 (en) | 2009-12-23 |
BRPI0914233A2 (pt) | 2015-11-03 |
CO6351726A2 (es) | 2011-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
CR20120427A (es) | Derivados de pirazol como inhibidores de jak | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
UY32351A (es) | Compuestos de pirimidinil indol para uso como inhibidores de atr | |
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
UY31069A1 (es) | Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones | |
NI201000003A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas. | |
NI201000004A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas. | |
UY30759A1 (es) | Compuestos quimicos | |
UY31639A1 (es) | Derivados de amida espirocíclica de fórmula i, sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolas, procesos de preparación y aplicaciones | |
UY33078A (es) | Derivados de imidazoquinolina | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
GT201200321A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
ECSP14013215A (es) | Compuestos novedosos | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
UY31922A (es) | Compuestos | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY31864A (es) | Derivados de urea hetericíclica y métodos de uso de los mismos-332 | |
UY31839A (es) | Compuestos | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
UY33723A (es) | ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?. | |
UY30982A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
CU20100250A7 (es) | Compuestos pirazólicos 436 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181106 |